Dr. David Sommerhalder, MD
Claim this profileNEXT Oncology
Expert in Tumors
Expert in Solid Tumors
24 reported clinical trials
32 drugs studied
Area of expertise
1Tumors
Global LeaderStage IV
Stage III
ER positive
2Solid Tumors
Global LeaderStage IV
Stage III
KRAS positive
Affiliated Hospitals
Clinical Trials David Sommerhalder, MD is currently running
IMM-1-104
for Solid Cancers
This trial is testing a new drug called IMM-1-104 to see if it can help treat advanced cancers with specific genetic changes. The drug works by blocking signals that make cancer cells grow.
Recruiting1 award Phase 1 & 2
Zotatifin
for Solid Tumors
This trial is testing a new drug called Zotatifin for patients with advanced cancers that haven't improved with standard treatments. The drug works by stopping cancer cells from making essential proteins, which may slow or stop the cancer.
Recruiting3 awards Phase 1 & 221 criteria
More about David Sommerhalder, MD
Clinical Trial Related1 year of experience running clinical trials · Led 24 trials as a Principal Investigator · 12 Active Clinical TrialsTreatments David Sommerhalder, MD has experience with
- Pembrolizumab
- BI 765179
- Ezabenlimab
- BMS-986460
- AMV564
- MPT-0118
Breakdown of trials David Sommerhalder, MD has run
Tumors
Solid Tumors
Cancer
Non-Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does David Sommerhalder, MD specialize in?
David Sommerhalder, MD focuses on Tumors and Solid Tumors. In particular, much of their work with Tumors has involved Stage IV patients, or patients who are Stage III.
Is David Sommerhalder, MD currently recruiting for clinical trials?
Yes, David Sommerhalder, MD is currently recruiting for 11 clinical trials in San Antonio Texas. If you're interested in participating, you should apply.
Are there any treatments that David Sommerhalder, MD has studied deeply?
Yes, David Sommerhalder, MD has studied treatments such as Pembrolizumab, BI 765179, Ezabenlimab.
What is the best way to schedule an appointment with David Sommerhalder, MD?
Apply for one of the trials that David Sommerhalder, MD is conducting.
What is the office address of David Sommerhalder, MD?
The office of David Sommerhalder, MD is located at: NEXT Oncology, San Antonio, Texas 78229 United States. This is the address for their practice at the NEXT Oncology.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.